Genetic Technologies Ltd
NASDAQ:GENE
Genetic Technologies Ltd
NASDAQ:GENE
Price:
0.765
USD
Market Closed
Market Cap:
$2.5m
Relative Value
The Relative Value of one
GENE
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 0.765 USD,
Genetic Technologies Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GENE Relative Value
HIDDEN
Multiples Across Competitors
GENE Competitors Multiples
Genetic Technologies Ltd Competitors
Genetic Technologies Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Genetic Technologies Ltd
NASDAQ:GENE
|
52.1m USD | 14.1 | -5.4 | -7.4 | -7.4 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
951.6B USD | 334 | 3 954.6 | 1 133.2 | 2 182.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
176.9B USD | 4 | 26.4 | 18.4 | 24.7 | |
| US |
|
Danaher Corp
NYSE:DHR
|
134.4B USD | 5.5 | 37.2 | 18.9 | 27.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
32.5B CHF | 5 | 34.3 | 25.6 | 25.6 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
266.5B CNY | 6 | 17.8 | 17.8 | 17.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.6B USD | 4.5 | 24.5 | 18 | 21.3 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.4B USD | 9.3 | 45.7 | 29.5 | 37.1 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.2B USD | 1.7 | 20.9 | 11.7 | 17.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
24.2B USD | 6 | 27.9 | 20.8 | 23.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
